Denise Hubert, Poot Jacqueline, Jiménez Maribel, Ambit Audrey, Herrmann Daland C, Vermeulen Arno N, Coombs Graham H, Mottram Jeremy C
Wellcome Centre for Molecular Parasitology and Division of Infection & Immunity, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow, UK.
BMC Mol Biol. 2006 Nov 13;7:42. doi: 10.1186/1471-2199-7-42.
Visceral leishmaniasis caused by members of the Leishmania donovani complex is often fatal in the absence of treatment. Research has been hampered by the lack of good laboratory models and tools for genetic manipulation. In this study, we have characterised a L. infantum line (JPCM5) that was isolated from a naturally infected dog and then cloned. We found that JPCM5 has attributes that make it an excellent laboratory model; different stages of the parasite life cycle can be studied in vitro, it is accessible to genetic manipulation and it has retained its virulence. Furthermore, the L. infantum JPCM5 genome has now been fully sequenced.
We have further focused our studies on LiCPA, the L. infantum homologue to L. mexicana cysteine peptidase CPA. LiCPA was found to share a high percentage of amino acid identity with CPA proteins of other Leishmania species. Two independent LiCPA-deficient promastigote clones (DeltaLicpa) were generated and their phenotype characterised. In contrast to L. mexicana CPA-deficient mutants, both clones of DeltaLicpa were found to have significantly reduced virulence in vitro and in vivo. Re-expression of just one LiCPA allele (giving DeltaLicpa::CPA) was sufficient to complement the reduced infectivity of both DeltaLicpa mutants for human macrophages, which confirms the importance of LiCPA for L. infantum virulence. In contrast, in vivo experiments did not show any virulence recovery of the re-expressor clone DeltaLicpaC1::CPA compared with the CPA-deficient mutant DeltaLicpaC1.
The data suggest that CPA is not essential for replication of L. infantum promastigotes, but is important for the host-parasite interaction. Further studies will be necessary to elucidate the precise roles that LiCPA plays and why the re-expression of LiCPA in the DeltaLicpa mutants complemented the gene deletion phenotype only in in vitro and not in in vivo infection of hamsters.
由杜氏利什曼原虫复合体成员引起的内脏利什曼病若不治疗往往会致命。由于缺乏良好的实验室模型和基因操作工具,相关研究受到了阻碍。在本研究中,我们对从一只自然感染犬分离并克隆得到的婴儿利什曼原虫株系(JPCM5)进行了特性分析。我们发现JPCM5具有使其成为优秀实验室模型的特性;该寄生虫生命周期的不同阶段可在体外进行研究,易于进行基因操作且保留了其毒力。此外,婴儿利什曼原虫JPCM5基因组现已完成全序列测定。
我们进一步将研究重点聚焦于婴儿利什曼原虫中与墨西哥利什曼原虫半胱氨酸蛋白酶CPA同源的LiCPA。发现LiCPA与其他利什曼原虫物种的CPA蛋白具有较高的氨基酸同一性百分比。我们构建了两个独立的LiCPA缺陷型前鞭毛体克隆(DeltaLicpa)并对其表型进行了表征。与墨西哥利什曼原虫CPA缺陷型突变体不同,DeltaLicpa的两个克隆在体外和体内的毒力均显著降低。仅重新表达一个LiCPA等位基因(得到DeltaLicpa::CPA)就足以弥补两个DeltaLicpa突变体对人巨噬细胞感染力降低的问题,这证实了LiCPA对婴儿利什曼原虫毒力的重要性。相比之下,体内实验表明,与CPA缺陷型突变体DeltaLicpaC1相比,重新表达克隆DeltaLicpaC1::CPA并未显示出任何毒力恢复。
数据表明CPA对于婴儿利什曼原虫前鞭毛体的复制并非必需,但对宿主 - 寄生虫相互作用很重要。有必要进一步开展研究以阐明LiCPA所起的精确作用,以及为何在DeltaLicpa突变体中重新表达LiCPA仅在体外而非仓鼠体内感染中弥补了基因缺失表型。